The Intra-Meatal Application of Tadalafil Cream Versus Oral Administration Efficacy and Safety: Results from a Randomized, Two-Administration Route, Cross-Over Clinical Trial
<b>Background:</b> Tadalafil cream, a topically administered phosphodiesterase-5 inhibitor (PDE5), presents a potential alternative to oral PDE5 inhibitors like tadalafil for the treatment of erectile dysfunction (ED). This study evaluates the non-inferiority and potential superiority of tadalafil cream compared to oral tadalafil. <b>Methods:</b> This randomized controlled trial employed a cross-over design with two treatment periods of two weeks each, separated by a one-week washout phase. Thirty-five male participants aged 18-75 with diagnosed ED (International Index of Erectile Function-Erectile function: IIEF-EF score < 26) were randomized to receive either tadalafil cream or oral tadalafil. Tadalafil cream was applied topically, while tadalafil was taken orally. The primary endpoint was IIEF-EF, and secondary endpoints were measured using the International Index of Erectile Function (IIEF) domain scores. Adverse events and treatment preferences were also assessed. <b>Results:</b> Tadalafil cream showed a higher increase in sexual function across all IIEF domains compared to oral tadalafil. The lower bounds of the confidence interval [improvement: final-baseline scores between tadalafil cream and oral tadalafil 0.72 (95% CI -2.72-4.15)] were above the non-inferiority margin of -3.22, confirming tadalafil cream's non-inferiority in the erectile function domain. In the intercourse satisfaction domain, tadalafil cream was superior to oral tadalafil. At the end of the trial, 88.57% of participants preferred tadalafil cream (95% CI 73.26%-96.79%), a result significantly above the non-inferiority margin that indicated superiority (<i>p</i> < 0.001). No systemic adverse events were reported for tadalafil cream, and significant differences in dizziness, headache, nasal congestion, and erythema were observed between the two treatments. <b>Conclusions:</b> Tadalafil cream is a safe and effective treatment for erectile dysfunction, demonstrating non-inferiority and potential superiority over oral tadalafil, with a high patient preference. Its topical administration offers a promising alternative for patients, particularly those with cardiovascular diseases where oral PDE5 inhibitors are contraindicated or less well tolerated.
Authors
- Daniel‐Corneliu Leucuta (ORCID: https://orcid.org/0000-0003-4218-8622)
- Ioan Coman
- Nicolae Crişan (ORCID: https://orcid.org/0000-0002-1087-775X)
- Florin Ioan Elec (ORCID: https://orcid.org/0000-0002-0803-2387)
- Dan Eniu (ORCID: https://orcid.org/0000-0002-6988-2828)
- Martina-Luciana Pintea-Trifu (ORCID: https://orcid.org/0000-0001-8801-5407)
- Dragoș-Mihail Trifu
Institutions
- Iuliu Hațieganu University of Medicine and Pharmacy (RO)
Publication Details
- Journal
- Journal of Clinical Medicine
- Published
- 2024-10-31
- DOI
- https://doi.org/10.3390/jcm13216557
- Citations
- 1
- Primary Topic
- Sexual function and dysfunction studies
- Type
- article
- Field-Weighted Citation Impact
- 0.39